Biomarin Pharmaceutical Inc

SCHRODER INVESTMENT MANAGEMENT GROUP BMRN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

167,525

Value ($000)

9,956

Weight

0.0%

2020 Q1 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	9,956	0.0%	167,525	12/31/2025
2025 Q2	8/13/2025	5,073	0.0%	92,281	6/30/2025
2025 Q1	5/13/2025	11,882	0.0%	168,080	3/31/2025
2024 Q4	2/12/2025	14,393	0.0%	218,964	12/31/2024
2024 Q3	11/13/2024	9,099	0.0%	129,449	9/30/2024
2024 Q2	8/12/2024	18,903	0.0%	229,599	6/30/2024
2024 Q1	5/14/2024	21,843	0.0%	250,093	3/31/2024
2023 Q4	2/14/2024	26,074	0.0%	270,417	12/31/2023
2023 Q3	11/14/2023	11,389	0.0%	128,723	9/30/2023
2023 Q2	8/11/2023	12,032	0.0%	138,805	6/30/2023
2023 Q1	5/11/2023	13,600	0.0%	139,859	3/31/2023
2022 Q4	2/10/2023	14,383	0.0%	138,983	12/31/2022
2022 Q3	11/14/2022	9,165	0.0%	108,116	9/30/2022
2022 Q2	8/11/2022	1,007	0.0%	12,157	6/30/2022
2022 Q1	5/16/2022	542	0.0%	6,963	3/31/2022
2021 Q4	2/14/2022	435	0.0%	4,922	12/31/2021
2021 Q3	11/12/2021	373	0.0%	4,827	9/30/2021
2021 Q2	8/13/2021	427	0.0%	5,110	6/30/2021
2021 Q1	5/28/2021	298	0.0%	3,940	3/31/2021
2020 Q4	2/16/2021	338	0.0%	3,863	12/31/2020
2020 Q3	11/13/2020	295	0.0%	3,941	9/30/2020
2020 Q2	8/13/2020	528	0.0%	4,283	6/30/2020
2020 Q1	5/15/2020	398	0.0%	4,818	3/31/2020